[Federal Register Volume 85, Number 97 (Tuesday, May 19, 2020)]
[Notices]
[Page 30007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10689]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2020-0087]


Qualification of Drivers; Exemption Applications; Implantable 
Cardioverter Defibrillators

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of correction; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: FMCSA corrects the State of domicile for one individual listed 
in its April 15, 2020, notice requesting comments on the receipt of 
applications from five individuals for an exemption from the 
prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) 
against operation of a commercial motor vehicle (CMV) by persons with a 
current clinical diagnosis of myocardial infarction, angina pectoris, 
coronary insufficiency, thrombosis, or any other cardiovascular disease 
of a variety known to be accompanied by syncope (transient loss of 
consciousness), dyspnea (shortness of breath), collapse, or congestive 
heart failure. The Agency also extends the public comment period for 
that notice.

DATES: This correction is effective May 19, 2020. The comment period 
for the notice published April 15, 2020, at 85 FR 21061, is extended by 
30 days. Comments must be received on or before June 15, 2020.

ADDRESSES: You may submit comments identified by the Federal Docket 
Management System (FDMS) Docket ID FMCSA-2020-0087 using any of the 
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov/docket?D=FMCSA-2020-0087. Follow the online 
instructions for submitting comments.
     Mail: Docket Management Facility; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, 
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140, 
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., 
ET, Monday through Friday, except Federal Holidays.
     Fax: (202) 493-2251.
    To avoid duplication, please use only one of these four methods. 
See the ``Public Participation'' portion of the SUPPLEMENTARY 
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, (202) 366-4001, [email protected], FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., 
ET, Monday through Friday, except Federal holidays. If you have 
questions regarding viewing or submitting material to the docket, 
contact Docket Operations, (202) 366-9826.

SUPPLEMENTARY INFORMATION: On April 15, 2020, (85 FR 21061), FMCSA 
published a notice regarding five individuals requesting an exemption 
from the physical qualification standard found in Sec.  391.41(b)(4), 
which states that a person is physically qualified to drive a CMV if 
that person has no current clinical diagnosis of myocardial infarction, 
angina pectoris, coronary insufficiency, thrombosis, or any other 
cardiovascular disease of a variety known to be accompanied by syncope, 
dyspnea, collapse, or congestive cardiac failure. The notice 
referenced, in error, Minnesota as the State of domicile for the 
applicant, Theodore J. Engelke. Mr. Engelke's correct State of domicile 
is Wisconsin.
    In addition, FMCSA extends the comment period to ensure that 
interested parties have sufficient time to review and comment on the 
exemption applications.

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020-10689 Filed 5-18-20; 8:45 am]
BILLING CODE 4910-EX-P